Adenocarcinoma lung cancer

An overview of adenocarcinoma lung cancer 
Adenocarcinoma is one of the most complicated forms of lung cancer from his lung metastases in different regions and thus a serious impairment of lung function. Each tumor has seen its clinical importance because of its nature and place, in this case, the adenocarcinoma of the lung as a truly critical and requires extensive clinical measures to help patients recover from this deadly cancer.
 
While briefly explain the characteristics of adenocarcinoma of the lung, oncologists term it as a metastasis. In view of this special quality of metastases to the cancer cells spread to different regions of the lung blood vessels, lymph nodes or direct invasion of tissue structures. The oncologists conduct extensive clinical work-up and investigations on the origin, the extent of metastases and foci involving the entire lung or part of the lung / lung or the involvement of different organs must be delineated. Due to the nature of the structures spread to other organs, in women, there are studies that will determine the status of the uterus and ovaries in addition to studying the spread to other organs performed.
 
Adenocarcinoma of the lung has the most complex metastatic process, and because of his conduct of its spread, the clinical approach thus represents a chemotherapy, radiotherapy and supportive therapy.
It is notable that the adenocarcinoma of the lung is among pulmonary neoplasms, the epithelial origin should be mentioned together, unlike hemangiomas, etc. The pulmonary adenocarcinoma is a malignant neoplasm.
Patients with adenocarcinoma of the lung are signs of intense pain, the experience of some shortness of breath, dyspnea and cough. These are the characters who exist in a patient who has not yet been diagnosed with cancer of the lungs, and if have not subsided after the therapy, the symptoms, then the patient in a clinical oncologist referred to exclude conditions such as this type of lung cancer .


Because therapy for adenocarcinoma of the lung, a specific course of treatment includes surgery and, depending on the extent of metastases in the course of treatment, patients are also special diets, as well as novel therapies that given laser beam radiation therapy, etc. The remission of adenocarcinoma depends on how early how early the cancer is diagnosed and the patient has started to receive chemotherapy and related treatment planning by clinical oncologists and also depend on the patient's health status, to carry the toxic effects of therapy. To overcome this deadly disease, the physician and the patient has to work as a team to fight the battle against this terrible disease.


The treatment regimen that is followed in patients with adenocarcinoma of the lung often a combination of chemotherapy drugs such as cyclophosphamide + lomustine + methotrexate, in which the response rate is 14-38%, hexamethylmelamine + doxorubicin, and methotrexate (13% -32%), methotrexate + doxorubicin + cyclophosphamide + lomustine (13% -24%), cyclophosphamide + doxorubicin + cisplatin (0-36%), cyclophosphamide + bleomycin + cisplatin (20%), mitomycin C + vinblastine + cisplatin (26% -33%), cyclophosphamide + doxorubicin + etoposide + cisplatin (29%) and vindesine, and cisplatin (33%). These therapies are considered for different patients with different clinical presentations of lung adenocarcinoma.